Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Merck Forecasts Global Molnupiravir Revenues Of $5bn-$7bn Through 2022
Oct 28 2021
•
By
Jessica Merrill
Merck forecast billions in revenue coming from molnupiravir • Source: Alamy
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Earnings
More from Business